[Monoclonal antibodies in diagnosis and therapy].
The value of monoclonal antibodies (mAb) produced against renal, bladder and prostate cancer antigens is demonstrated. These mAb allow a molecular classification of urological cancers as well as therapeutic approaches in cancer treatment. Anti-T-cell mAb can also be used in cellular rejection of kidney transplants.
Huland
H
H
Urologische Klinik, FU Berlin, Klinikum Steglitz.
Hammerer
P
P
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology*; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000628:therapy; D016030:Kidney Transplantation; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000628:therapy; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis* / Q000628:therapy
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D000951:Antigens, Neoplasm
Monoklonale Antikörper in Diagnostik und Therapie.